The innate immune effector APOBEC3, a new link between viruses and cancer

Project: Research

Description

After the spontaneous mutations linked with aging, the second most
frequent type of mutations observed in cancer genomes is attributed to the
APOBEC3 enzymes (Apolipoprotein B Editing Catalytic subunits 3 or A3s).
A3s are normal components of the innate immune system restricting viruses
and retroelements by cytidine deamination. The goal of this project is to
understand the chain of events leading to the APOBEC3 mutational
signature in cancer. We will focus on lung cancer as a large proportion of
these tumors display A3-induced mutations.
There are several outstanding questions about A3 mutagenicity.
i. What are the events inducing A3 expression?
A3 mutagenesis in head and neck squamous cell carcinomas has been
linked with HPV infection. We will test whether a lung viral infection can
trigger A3-associated mutations.
ii. What are the pathways regulating A3 expression?
Some A3 mRNAs are constitutively expressed in lung cells whereas no
protein can be detected. Thus, we will investigate the post transcriptional
control of A3 transcripts.
iii. Are human A3s oncogenic in mouse models?
We will evaluate human A3s mutagenic activity in mice. We will notably
combine heterologous A3 expression with cigarette smoke exposure to test
whether tobacco carcinogens can potentiate A3 mutagenesis.
Short titleAPOBEC3 mutational signature in cancer
StatusActive
Effective start/end date1/01/1831/12/19

Keywords

  • NARILIS